Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/17/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Robert A. Fildes

Wrong Dr. Robert A. Fildes?

President

Sb2 , Inc.
 
Background

Employment History

Board Memberships and Affiliations

Education

  • PhD , Biochemical Genetics
    University of London
  • DCC degree , Microbial Biochemistry
    University of London
  • Ph.D. , Biochemical Genetics
    University of London
  • D.C.C. degree , Microbial Biochemistry
    University of London
62 Total References
Web References
Inimex Pharmaceuticals - Innate Immunity - Innate Immune Response - Innate Immune - Adpative Immunity
www.inimexpharma.com, 17 Mar 2013 [cached]
Robert Fildes, Ph.D. (Chairman) Dr. Fildes currently serves as President of SB2 Inc. Dr. Fildes has extensive experience in the biotechnology and pharmaceutical sector, including terms as President & CEO of Cetus Corporation, President of Biogen Inc., and Vice President of Operations for the Industrial Division of Bristol-Myers Squibb Company. He is currently a director on numerous boards of publicly and privately traded biotechnology companies. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry as well as a Ph.D. in Biochemical Genetics from the University of London.
Investor Relations - Directors & Management Team
www.ljpc.com, 8 Dec 2011 [cached]
Robert A. Fildes, Ph.D.
...
Robert A. Fildes, Ph.D. President, SB2, Inc.
Robert A. Fildes, Ph.D. has been a director since 1991. Since January 1998, Dr. Fildes has served as President of SB2, Inc., a privately held company that licenses antibody technology. From June to December 1998, Dr. Fildes served as Chief Executive Officer of Atlantic Pharmaceuticals, a publicly held company in the field of biotechnology. From 1993 to 1997, Dr. Fildes was the Chairman and Chief Executive Officer of Scotgen Biopharmaceuticals, Inc., a privately held company in the field of human monoclonal antibody technology. From 1990 to 1993, Dr. Fildes was an independent consultant in the biopharmaceutical industry. He was the president and Chief Executive Officer of Cetus Corporation, a publicly held biotechnology company, from 1982 to 1990. From 1980 to 1982, Dr. Fildes was the President of Biogen, Inc., which merged with IDEC Pharmaceuticals Corporation in 2003 to form Biogen Idec, a publicly held biopharmaceutical company, and from 1975 to 1980, he was the Vice President of Operations for the Industrial Division of Bristol-Myers Squibb Company. From April 2002 to April 2003, Dr. Fildes was a director of Polymerat Pty. Ltd. (now Bio-Layer Pty. Ltd.), a privately held company that develops surfaces for carrying out biological reactions. Dr. Fildes is currently a director of Inimex Pharmaceuticals, Inc., a privately held Canadian biotechnology company. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry and a Ph.D. in Biochemical Genetics from the University of London.
In order to comply with Delaware ...
www.sec.gov, 14 April 2004 [cached]
In order to comply with Delaware law and our certificate of incorporation and bylaws, the board of directors has resolved to fill the vacancy created by Dr. Thompson's retirement by moving Robert A. Fildes into Class III upon Dr. Thompson's retirement.
...
Because Dr. Fildes has served as a director for three years, the maximum term permitted by law, Dr. Fildes will stand for re-election this year for a one year term as a Class III director.After serving the one year term as a Class III director, Dr. Fildes, together with the other directors in the class at that time, is expected to stand for re-election for a three year term as a Class III director.
...
Dr. Fildes is nominated for election to Class III of the board of directors to serve a one year term ending at the 2005 annual meeting and until his successor is elected and qualified.Our board of directors recommends that you vote FOR the following nominee.
Robert A. Fildes, Ph.D., 65, has been a director since 1991.Since January 1998, Dr. Fildes has served as President of SB2, Inc., a privately held company that licenses antibody technology.From June to December 1998, Dr. Fildes served as Chief Executive Officer of Atlantic Pharmaceuticals, a publicly held company in the field of biotechnology.From 1993 until August 1997, Dr. Fildes was the Chairman and Chief Executive Officer of Scotgen Biopharmaceuticals, Inc., a privately held company in the field of human monoclonal antibody technology.From 1990 to 1993, Dr. Fildes was an independent consultant in the biopharmaceutical industry.He was the President and Chief Executive Officer of Cetus Corporation, a publicly held biotechnology company, from 1982 to 1990.From 1980 to 1982, Dr. Fildes was the President of Biogen, Inc., a publicly held biopharmaceutical company, and from 1975 to 1980, he was the Vice President of Operations for the Industrial Division of Bristol-Myers Squibb Company.From April 2002 to April 2003, Dr. Fildes was a director of Polymerat Pty.Ltd. (now Bio-Layer Pty.Ltd.), a privately held company that develops surfaces for carrying out biological reactions.Dr. Fildes is currently a director of Cytovax Biotechnologies, Inc., a publicly held company that develops and commercializes vaccines and therapeutic products for the prevention and treatment of infectious diseases.Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry and a Ph.D. in Biochemical Genetics from the University of London.
...
, ROBERT A. FILDES
Twinstrand Therapeutics
www.twinstrand.com, 27 June 2009 [cached]
Robert A Fildes, PhD, Chair Former President & CEO, Cetus Corporation Former President, Biogen Inc.
Dr. Fildes is currently a director of La Jolla Pharmaceutical Company (a public American biotechnology company) and Chairman of Inimex Pharmaceuticals Inc. (a private Canadian biotechnology company). He has more than 30 years of experience in the biotechnology and pharmaceutical industry. Dr. Fildes has served as Chairman & CEO of Scotgen Biopharmaceuticals Inc., President & CEO of Cetus Corporation, and President of Biogen Inc. He spent 15 years as a senior manager in big pharmaceutical companies, first with GlaxoSmithKline and then as Vice President of Operations for the Bristol-Myers Squibb Company. Dr. Fildes holds a DCC degree in Microbial Biochemistry and a PhD in Biochemical Genetics from the University of London.
Dr. Robert Fildes
www.cmcapital.com, 5 Feb 2011 [cached]
Dr. Robert Fildes
...
Dr. Robert Fildes
Dr Fildes was President and CEO of Cetus Corporation, a company that used biotechnology to discover and develop PCR technology, genetically engineered human proteins and monoclonal antibodies. Under Dr Fildes leadership this organisation grew from a small research boutique into a focussed international biopharmaceutical company employing over 1,000 people with skills and facilities to discover, develop, manufacture and sell therapeutic products for human treatment.
Prior to Cetus, he was the President of Biogen Inc. the US subsidiary of Biogen NV, Geneva. Dr Fildes was also the VP of Operations for Bristol Myers Corporation, a global US based pharmaceutical company. As such he was responsible for managing a global staff of 2,000 engaged in the technical development and commercial manufacture of a wide range of drug products.
Dr Fildes obtained his doctorate from the University of London. He has served on the board of directors of numerous bioechnology companies. Currently he is President of SB2 Inc. a biotechnology licensing company, a director of La Jolla Pharmaceuticals (a public San Diego company); Chairman of Inimex and Twinstrand(Private Canadian companies) andVaxart (Private California based company).
...
Dr. Robert Fildes
Other People with the name "Fildes":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304